Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark G. Faber
Mark G. Faber
Roswell Park Cancer Institute
Medicine
Oncology
Internal medicine
Mutant
Daunorubicin
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Emerging trends of therapy related myeloid neoplasms following modern cancer therapeutics in the United States.
2021
Scientific Reports
Abhay Singh
Megan M. Herr
Elizabeth A. Griffiths
Amanda Przespolewski
Mark G. Faber
Chebli Mrad
Eunice S. Wang
Theresa Hahn
Swapna Thota
Show All
Source
Cite
Save
Citations (0)
DNMT3A and TET2 mutant Clonal Hematopoiesis May Drive a Proinflammatory State and Predict Enhanced Response to Immune Checkpoint Inhibitors
2021
Blood
Abhay Singh
Nuria Mencia-Trinchant
Elizabeth A. Griffiths
Mahesh Swaminathan
Matthew Gravina
Rutaba Tajammal
Mark G. Faber
M. S. Ernstoff
LunBiao Yan
Eti Sinha
Megan M. Herr
Duane C. Hassane
Monica L. Guzman
Amanda Przespolewski
Eunice S. Wang
Swapna Thota
Show All
Source
Cite
Save
Citations (0)
Outcomes Of Adult Acute Myeloid Leukemia Treated With Gemtuzumab-Ozogamicin: Cue To Optimized Chemotherapy Backbone
2021
Clinical Lymphoma, Myeloma & Leukemia
Abhay Singh
Swapna Thota
Terrence J. Bradley
Elizabeth A. Griffiths
Mark G. Faber
S. Sadek
Amanda Przespolewski
James E. Thompson
Jeffrey Baron
Cronin Tara
Kristopher Attwood
Ellen Madarang
Justin M. Watts
Eunice S. Wang
Show All
Source
Cite
Save
Citations (0)
Mutant PPM1D and TP53 populate the hematopoietic compartment after peptide receptor radionuclide therapy (PRRT) exposure.
2021
Journal of Clinical Oncology
Abhay Singh
Nuria Mencia-Trinchant
Elizabeth A. Griffiths
Medhavi Gupta
Matthew Gravina
Rutaba Tajammal
Mark G. Faber
LunBiao Yan
Eti Sinha
Duane C. Hassane
Monica L. Guzman
Renuka Iyer
Eunice S. Wang
Swapna Thota
Show All
Source
Cite
Save
Citations (0)
1